Pages that link to "Q28343848"
Jump to navigation
Jump to search
The following pages link to Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy (Q28343848):
Displaying 50 items.
- Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes (Q22253414) (← links)
- Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis (Q24307293) (← links)
- Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis (Q24678823) (← links)
- Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy (Q26748618) (← links)
- Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3 (Q28396645) (← links)
- Enhancing or eliminating signals for cell survival to treat disease. (Q30498584) (← links)
- Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2. (Q33632353) (← links)
- Novel insights into hydrogen sulfide--mediated cytoprotection. (Q33830124) (← links)
- Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance (Q33863961) (← links)
- STAT3 balances myocyte hypertrophy vis-à-vis autophagy in response to Angiotensin II by modulating the AMPKα/mTOR axis. (Q33883642) (← links)
- P53 inhibition exacerbates late-stage anthracycline cardiotoxicity (Q34048273) (← links)
- Hydrogen sulfide and ischemia-reperfusion injury (Q34049947) (← links)
- Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? (Q34102834) (← links)
- A crucial role of activin A-mediated growth hormone suppression in mouse and human heart failure (Q34116906) (← links)
- Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair (Q34357753) (← links)
- Cardiac hypertrophy and failure: lessons learned from genetically engineered mice (Q34418993) (← links)
- Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation (Q34550563) (← links)
- Calreticulin-STAT3 signaling pathway modulates mitochondrial function in a rat model of furazolidone-induced dilated cardiomyopathy (Q34789646) (← links)
- Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection (Q34805921) (← links)
- Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? (Q34974091) (← links)
- Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species (Q35313598) (← links)
- Inflammation and chronic heart failure-potential therapeutic role of intravenous immunoglobulin (Q35756990) (← links)
- FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity (Q35832107) (← links)
- New frontiers in heart hypertrophy during pregnancy. (Q36190273) (← links)
- The varying faces of IL-6: From cardiac protection to cardiac failure. (Q36368339) (← links)
- Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction (Q36371225) (← links)
- Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects (Q36497007) (← links)
- The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. (Q36630478) (← links)
- Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity (Q36637796) (← links)
- α₁A-adrenergic receptors regulate cardiac hypertrophy in vivo through interleukin-6 secretion (Q36776721) (← links)
- Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition (Q36800953) (← links)
- Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress (Q36895459) (← links)
- STAT transcription in the ischemic heart (Q36895468) (← links)
- Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein (Q37024066) (← links)
- Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death (Q37033644) (← links)
- Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts (Q37184746) (← links)
- Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics (Q37203741) (← links)
- Catecholamine-induced cardiac hypertrophy in rats is associated with the activation of p70 kinase and c-Jun NH(2)-terminal kinase 2. (Q37284655) (← links)
- Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death. (Q37292925) (← links)
- Hydrogen sulfide mediates cardioprotection through Nrf2 signaling (Q37328256) (← links)
- Maternal dietary restriction during the periconceptional period in normal-weight or obese ewes results in adrenocortical hypertrophy, an up-regulation of the JAK/STAT and down-regulation of the IGF1R signaling pathways in the adrenal of the postnata (Q37331095) (← links)
- Novel insights into the role of cardiotrophin-1 in cardiovascular diseases (Q37342253) (← links)
- Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity. (Q37412473) (← links)
- JAK-STAT signaling and myocardial glucose metabolism (Q37421817) (← links)
- Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy (Q37467862) (← links)
- gp130-mediated pathway and heart failure (Q37608600) (← links)
- Proinflammatory cytokines in heart failure: double-edged swords (Q37734294) (← links)
- STAT3 and cardiac remodeling (Q37734934) (← links)
- Cardiotrophin-1 in cardiovascular regulation. (Q37833050) (← links)
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes. (Q37833892) (← links)